Key result
Positive programmed ventricular stimulation identifies ~43% major arrhythmic event risk in myocardial scar with LVEF ≥40%.
Why the study?
No recommendations guide prophylactic ICD use in patients with myocardial scarring and LVEF ≥40%, despite representing most sudden cardiac deaths.
Does programmed ventricular stimulation predict major arrhythmic events in patients with myocardial scarring and LVEF ≥40%?
Cohort (n=168)
Does programmed ventricular stimulation predict major arrhythmic events in patients with myocardial scarring and LVEF ≥40%?
Programmed ventricular stimulation provides high negative predictive value for major arrhythmic events in patients with myocardial scar and LVEF ≥40%, aiding in risk stratification for prophylactic ICD placement.
Answers are grounded in this paper and cite their sources.
Supports PVS for arrhythmic risk stratification in myocardial scar with LVEF ≥40%; leaves open need for trials on ICD decisions.
BACKGROUND: Implantable cardioverter defibrillators (ICDs) are recommended in patients with left ventricular ejection fraction (LVEF) of ≤35%. However, no recommendation exists to guide the use of prophylactic ICD in patients with less altered LVEF and myocardial scarring, even though they represent most of sudden cardiac deaths. OBJECTIVE: This study aimed to evaluate the prognostic value of programmed ventricular stimulation (PVS) in patients with mildly reduced or preserved LVEF. METHODS: Patients who underwent PVS with myocardial scarring and LVEF of ≥40% were included. The primary endpoint was the occurrence of a major arrhythmic event (MAE), namely sudden cardiac death, ventricular tachycardia/fibrillation, and appropriate ICD therapy. RESULTS: A total of 168 patients were included (mean age, 62 ± 13 years; LVEF, 54% ± 9%). Indication for PVS was mostly nonsustained ventricular tachycardia and/or syncope (83%). Patients with post-myocardial infarction represented approximately half of the cases (52%). Inducibility during PVS was observed in 21 patients (13%). Over a mean follow-up of 46 ± 38 months, an MAE occurred in 9 patients with positive PVS (43%) vs 4 patients (2.7%) with negative PVS. Inducibility during PVS provided high rule-out performance with a 97% negative predictive value for the prediction of MAE and a fair rule-in performance with a 43% positive predictive value (sensitivity 69%; specificity 92%). CONCLUSION: PVS is a useful tool to discriminate patients with myocardial scar and LVEF of ≥40% at an increased arrhythmic risk. Effective utilization of ICD may be anticipated in the case of positive PVS, whereas noninducible patients are at a lower MAE risk.
No takes yet. Share an insight, caveat, or question.
Soris et al. (2025) conducted a cohort in Myocardial scarring and mildly reduced or preserved ejection fraction (n=168). Programmed ventricular stimulation (positive) vs. Programmed ventricular stimulation (negative) was evaluated on Major arrhythmic event (sudden cardiac death, ventricular tachycardia/fibrillation, and appropriate ICD therapy). Positive programmed ventricular stimulation identified a higher risk of major arrhythmic events compared to negative stimulation in patients with myocardial scar and LVEF ≥40%.
Synapse has enriched 10 related papers. Consider them for comparative context: